Home>>LSP-249

LSP-249

Catalog No.GC62700

LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.

Products are for research use only. Not for human use. We do not sell to patients.

LSP-249 Chemical Structure

Cas No.: 1801253-04-2

Size Price Stock Qty
10mM (in 1mL DMSO)
$79.00
In stock
5 mg
$72.00
In stock
10 mg
$117.00
In stock
25 mg
$225.00
In stock
50 mg
$360.00
In stock
100 mg
$585.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1].

[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.

Reviews

Review for LSP-249

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for LSP-249

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.